These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


650 related items for PubMed ID: 25475403

  • 1. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K.
    Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
    [Abstract] [Full Text] [Related]

  • 2. Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria.
    Iwasaki C, Moriyama T, Tanaka K, Takei T, Nitta K.
    J Nephropathol; 2016 Apr; 5(2):72-8. PubMed ID: 27152293
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
    Tan M, Li W, Zou G, Zhang C, Fang J.
    Kidney Blood Press Res; 2015 Apr; 40(2):200-6. PubMed ID: 25924707
    [Abstract] [Full Text] [Related]

  • 4. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 5. Tonsillectomy plus steroid pulse therapy is the most effective treatment in adult patients with C-Grade I IgA nephropathy, and the weight of the extracted palatine tonsils and Yamamoto scale have no significant correlation with the effects of this treatment.
    Kondo N, Moriyama T, Tachikawa M, Tomita E, Hattori A, Yamamura Y, Nonaka M.
    Auris Nasus Larynx; 2019 Oct 14; 46(5):764-771. PubMed ID: 30665673
    [Abstract] [Full Text] [Related]

  • 6. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
    Komatsu H, Sato Y, Miyamoto T, Tamura M, Nakata T, Tomo T, Nishino T, Miyazaki M, Fujimoto S.
    Clin Exp Nephrol; 2016 Feb 14; 20(1):94-102. PubMed ID: 26123429
    [Abstract] [Full Text] [Related]

  • 7. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
    Mizerska-Wasiak M, Małdyk J, Pańczyk-Tomaszewska M, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Miklaszewska M, Pietrzyk J, Pukajło-Marczyk, Zwolińska D, Szczepańska M, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Feb 14; 873():79-86. PubMed ID: 26269025
    [Abstract] [Full Text] [Related]

  • 8. Effect of hematuria on the kidney disease progression in IgA nephropathy patients with mild proteinuria and well-preserved renal function.
    Liu Y, Chen H, Wang H, Li Z, Li H, Wang F, Jia J, Li D, Yan T.
    Int Immunopharmacol; 2023 Sep 14; 122():110635. PubMed ID: 37453157
    [Abstract] [Full Text] [Related]

  • 9. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T, Nakayama K, Ochi A, Amemiya N, Tsuruta Y, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.
    Clin Exp Nephrol; 2012 Apr 14; 16(2):231-7. PubMed ID: 22038185
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function.
    Ogura S, Moriyama T, Miyabe Y, Karasawa K, Nitta K.
    Clin Exp Nephrol; 2021 Oct 14; 25(10):1103-1110. PubMed ID: 34101029
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function.
    Tan M, Fang J, Xu Q, Zhang C, Zou G, Wang M, Li W.
    Ren Fail; 2019 Nov 14; 41(1):875-882. PubMed ID: 31517550
    [Abstract] [Full Text] [Related]

  • 12. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria.
    Hoshino Y, Kaga T, Abe Y, Endo M, Wakai S, Tsuchiya K, Nitta K.
    Clin Exp Nephrol; 2015 Oct 14; 19(5):918-24. PubMed ID: 25672293
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
    Sato H, Ichikawa D, Okada E, Suzuki T, Watanabe S, Shirai S, Shibagaki Y.
    PLoS One; 2021 Oct 14; 16(5):e0251294. PubMed ID: 34043669
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characteristics of IgA nephropathy in advanced-age patients.
    Oshima Y, Moriyama T, Itabashi M, Takei T, Nitta K.
    Int Urol Nephrol; 2015 Jan 14; 47(1):137-45. PubMed ID: 25388352
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Jan 14; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 20. Severity of nephrotic IgA nephropathy according to the Oxford classification.
    Moriyama T, Nakayama K, Iwasaki C, Ochi A, Tsuruta Y, Itabashi M, Tsukada M, Takei T, Uchida K, Nitta K.
    Int Urol Nephrol; 2012 Aug 14; 44(4):1177-84. PubMed ID: 22231129
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.